Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Aftertreated solid synthetic organic polymer
Patent
1996-10-17
1999-07-20
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Aftertreated solid synthetic organic polymer
5147722, A61K 4700
Patent
active
059256834
ABSTRACT:
This relates to a composition of matter comprising partially hydrolyzed polyvinyl acetate solutions suitable for use as embolic agent precursors. In addition, a procedure for introducing the solutions into the human body to form precipitated embolic occlusion masses is shown. Finally, a procedure for treatment of hepatic tumors using portal vein embolism is described.
REFERENCES:
patent: 2160503 (1939-02-01), Herrmann
patent: 2657201 (1953-10-01), Nebel
patent: 3701771 (1972-10-01), Almen et al.
patent: 4364921 (1982-12-01), Speck et al.
patent: 4631188 (1986-12-01), Stoy et al.
patent: 5416223 (1995-05-01), Klaveness et al.
patent: 5443454 (1995-08-01), Tanabe et al.
patent: 5702361 (1997-12-01), Evans et al.
Novak, "Embolization materials" Interventional Radiology (1990) Dandlinger et al., ed., Thieme, NY, pp. 295-313.
Vinters et al., "The histotoxocity of cyanoacrylates: A selective review", Neuroradiology (1985) 27:279-291.
Sugawara et al., "Experimental investigations concerning a new liquid embolization method: Combined administration of ethanol-estrogen and polyvinyl acetate" Neurol. Med. Chir. (1993) 33:71-76.
Taki et al., "A new liquid material for embolization of arteriovenous malformations" AJNR (1990) 11:163-168.
Mandai et al., "Direct thrombosis of aneurysms with cellulose acetate polymer. Part I: Results of thrombosis in experimental aneurysms" J. Neurosurg. (1992) 77:497-500.
Takahashi et al., "Nonsurgical treatment of AVM: Development of new liquid embolization method" Advances in Surgery for Cerebral Stroke (1988) Suzuki, J., ed., Springer-Verlag. pp. 215-224.
Su et al., "Histopathological studies of a new liquid embolization method using estrogen-alcohol and polyvinyl acetate" Surg. Neurol. (1991) 36:4-11.
Janik et al., "Therapeutic embolization of the venous vascular bed with vilan 500 in animal experiments" Cs. Radiol. (1990) 44(1):44-50. (Translation from Czech to English by Quest Technology, Inc.).
Peregrin et al., "New material for therapeutic embolization in an animal experiment" Cs. Radiol. (1983) 37(1):27-33. (Translation from Czech to English by Quest Technology, Inc.).
Sugawara et al., "Experimental investigations concerning a new liquid embolization method: Combined administration of ethanol-estrogen and polyvinyl acetate" Neurol. Med. Chir. (Tokyo) (1993) 33:71-76.
Peregrin et al., "New occlusive agent for therapeutic embolization tested in dogs" Cardiovasc. Intervent. Radiol. (1984) 7(2):97-101.
Sadato et al., "Experimental study and clinical use of poly(vinyl acetate) emulsion as liquid embolisation material" Neuradiol. (1994) 36:634-641.
Luscher, P. and Wintermantel, E., A New Injectable Open-porous Implant System (Information Brochure) ETH Zurich, Wagistr. 23, 8952 Schlieren, Switzerland, 15 pages total.
Kinugasa et al., "Direct thrombosis of aneurysms with cellulose acetate polymer Part II. Preliminary clinical experience" J. Neurosurg. (1992) 77:501-507.
Kinugasa et al., "Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms: Angiographic findings, clinical experience, and histopathological study" Neurosurgery (1994) 34:694-701.
Noro, "Hydrolysis of polyvinyl acetate to polyvinyl alcohol" Polyvinyl Alcohol (1973) John Wiley & Sons, pp. 91-118.
Mizoi et al., "Surgical excision of giant cerebellar hemispheric arteriovenous malformations following preoperative embolization" J. Neurosurg. (1992) 76:1008-1011.
Akopyan et al., "Hydrolysis of polyvinylacetate" Zhurnal Prikladnol Khimii (1963) 336:1085-1090.
Medline Abstract 90263204. Janik et al.
Fay Zohreh
Target Therapeutics Inc.
LandOfFree
Liquid embolic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid embolic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid embolic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322348